Skip to main content
Larissa Furtado, MD, Pathology, Memphis, TN

LarissaVianaFurtadoMD

Pathology • Memphis, TN

Molecular Genetics, Anatomic Pathology, Clinical Pathology

Medical Director, Molecular Oncology

Join to view full profile

Dr. Furtado is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Furtado's full profile

Already have an account?

  • Office

    262 Danny Thomas Pl
    Memphis, TN 38105
    Phone+1 888-226-4343

Education & Training

  • University of Michigan
    University of MichiganFellowship, Molecular Genetic Pathology, 2012 - 2013
  • University of Utah Health
    University of Utah HealthResidency, Pathology-Anatomic and Clinical, 2008 - 2012
  • Other
    OtherClass of 2002

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2019 - 2025
  • TN State Medical License
    TN State Medical License 2019 - 2025
  • UT State Medical License
    UT State Medical License 2009 - 2022
  • IL State Medical License
    IL State Medical License 2013 - 2017
  • MI State Medical License
    MI State Medical License 2012 - 2013
  • American Board of Pathology Pathology - Anatomic/Pathology - Clinical
  • American Board of Pathology Clinical Informatics
  • American Board of Pathology Pathology - Molecular Genetic

Publications & Presentations

PubMed

Journal Articles

  • Original Contribution Tumor PD-L1 Expression in Malignant Pleural and Peritoneal Mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28–8 pharmDx Assays☆☆☆☆☆☆  
    Aliya N Husain, Georgios Deftereos, Larissa V Furtado, ScienceDirect

Press Mentions

  • Highs, Lows of Tumor Mutation Burden Testing
    Highs, Lows of Tumor Mutation Burden TestingSeptember 20th, 2022
  • CAP Publishes Guideline for PD-L1 Testing of Patients with Lung Cancer
    CAP Publishes Guideline for PD-L1 Testing of Patients with Lung CancerApril 17th, 2024
  • Association for Molecular Pathology Publishes Evidence-Based Recommendations for Tumor Mutational Burden Testing
    Association for Molecular Pathology Publishes Evidence-Based Recommendations for Tumor Mutational Burden TestingJune 7th, 2024

Committees

  • Reviewer, Molecular Methods Consensus Committee, Clinical and Laboratory Standard Institute (CLSI) 2014 - 2015
  • Junior Member, Clinical Practice Committee, Association for Molecular Pathology 2013 - 2014
  • Junior Member, Biochemical Genetics & Molecular Genetics Resource Committee, College of American Pathologists /American College of Medical Genetics and Genomics 2012 - 2013

Professional Memberships

Other Languages

  • Portuguese

Dr. Larissa Furtado, Dr. Larissa Furtado, MD, Dr. L Furtado, Dr. Larissa Viana Furtado